Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior.
Study Goal
The researchers aimed to propose mechanisms by which docosahexaenoic acid (DHA) influences serotonin receptor action and brain function, particularly in neuropsychiatric disorders.
Results Summary
The study suggests that DHA enhances serotonin receptor function by increasing postsynaptic neuron membrane fluidity, potentially improving cognitive and behavioral outcomes in disorders like ADHD, bipolar disorder, and schizophrenia. It also highlights that insufficient DHA levels, alongside genetic and developmental factors, may contribute to dysfunctional serotonin activity.
Population
General population with potential neuropsychiatric disorders (e.g., ADHD, bipolar disorder, schizophrenia).
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
omega-3 fatty acids | increase | cognitive function and behavior | brain disorders | - | improve | #1 |
vitamin D | increase | cognitive function and behavior | brain disorders | - | improve | #2 |
vitamin D hormone | increase | tryptophan hydroxylase 2 | - | - | transcriptionally activated | #3 |
EPA | increase | serotonin release from presynaptic neurons | - | - | increases | #4 |
EPA | decrease | E2 series prostaglandins | - | - | reducing | #5 |
DHA | increase | serotonin receptor action | - | - | influences | #6 |
DHA | increase | cell membrane fluidity in postsynaptic neurons | - | - | increasing | #7 |
optimizing vitamin D and marine omega-3 fatty acid intake | decrease | brain dysfunction | - | - | may help prevent and modulate the severity | #8 |
Serotonin regulates a wide variety of brain functions and behaviors. Here, we synthesize previous findings that serotonin regulates executive function, sensory gating, and social behavior and that attention deficit hyperactivity disorder, bipolar disorder, schizophrenia, and impulsive behavior all share in common defects in these functions. It has remained unclear why supplementation with omega-3 fatty acids and vitamin D improve cognitive function and behavior in these brain disorders. Here, we propose mechanisms by which serotonin synthesis, release, and function in the brain are modulated by vitamin D and the 2 marine omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Brain serotonin is synthesized from tryptophan by tryptophan hydroxylase 2, which is transcriptionally activated by vitamin D hormone. Inadequate levels of vitamin D (∼70% of the population) and omega-3 fatty acids are common, suggesting that brain serotonin synthesis is not optimal. We propose mechanisms by which EPA increases serotonin release from presynaptic neurons by reducing E2 series prostaglandins and DHA influences serotonin receptor action by increasing cell membrane fluidity in postsynaptic neurons. We propose a model whereby insufficient levels of vitamin D, EPA, or DHA, in combination with genetic factors and at key periods during development, would lead to dysfunctional serotonin activation and function and may be one underlying mechanism that contributes to neuropsychiatric disorders and depression. This model suggests that optimizing vitamin D and marine omega-3 fatty acid intake may help prevent and modulate the severity of brain dysfunction.